Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 708  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


This article has been cited by
1The moral economy of the pharmaceutical industry: Legitimising prices
Joan Busfield
Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine.2019;()136345931987947
[DOI]
2Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
Reed F. Beall,Jason W. Nickerson,Warren A. Kaplan,Amir Attaran,Heinz Fehrenbach
PLOS ONE.2016;11(2)e0148939
[DOI]
3Healthcare innovation and patent law’s ‘pharmaceutical privilege’: is there a pharmaceutical privilege? And if so, should we remove it?
Graham Dutfield
Health Economics, Policy and Law.2017;12(4)453
[DOI]
4Growth of high-quality metastable crystal of acetaminophen using solution-mediated phase transformation at low supersaturation
Riki Fujimoto,Mihoko Maruyama,Yoichiro Mori,Shino Okada,Hiroaki Adachi,Hiroshi Y. Yoshikawa,Kazufumi Takano,Satoshi Murakami,Hiroyoshi Matsumura,Tsuyoshi Inoue,Masayuki Imanishi,Katsuo Tsukamoto,Masashi Yoshimura,Yusuke Mori
Journal of Crystal Growth.2018;502(4)76
[DOI]
5IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report
Lyndon Jones,Björn Drobe,José Manuel González-Méijome,Lyle Gray,Timo Kratzer,Steve Newman,Jason J. Nichols,Arne Ohlendorf,Stephanie Ramdass,Jacinto Santodomingo-Rubido,Katrina L. Schmid,Donald Tan,Kah-Ooi Tan,Fuensanta A. Vera-Diaz,Yee-Ling Wong,Kate L. Gifford,Serge Resnikoff
Investigative Opthalmology & Visual Science.2019;60(3)M161
[DOI]
6Product lifecycle management through patents and regulatory strategies
Vandana Prajapati,Swagat Tripathy,Harish Dureja
Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing.2013;13(3)171
[DOI]
7A systems-level analysis of drug–target–disease associations for drug repositioning
Kayleigh D Rutherford,Gaston K Mazandu,Nicola J Mulder
Briefings in Functional Genomics.2018;17(1)34
[DOI]
8A systems-level analysis of drug–target–disease associations for drug repositioning
Preshita Desai,Sivagami Bhatt,Mahalaxmi Andheria
Briefings in Functional Genomics.2016;17(1)31
[DOI]
9Higher patient satisfaction with antidepressants correlates with earlier drug release dates across online user-generated medical databases
Scott Siskind,Roland C. Aydin,Punit Matta,Christian J. Cyron
Pharmacology Research & Perspectives.2017;5(5)e00355
[DOI]
10Higher patient satisfaction with antidepressants correlates with earlier drug release dates across online user-generated medical databases
Alexandra Hall,Georgios A. Antonopoulos
Pharmacology Research & Perspectives.2016;5(5)79
[DOI]
11Higher patient satisfaction with antidepressants correlates with earlier drug release dates across online user-generated medical databases
Basant Amarji,Sara Nidal Abed,Ujjawal Bairagi,Pran Kishore Deb,Omar Al-Attraqchi,Anup Avijit Choudhury,Rakesh K. Tekade
Pharmacology Research & Perspectives.2018;5(5)637
[DOI]
12Remote Controlled Autonomous Microgravity Lab Platforms for Drug Research in Space
Shimon Amselem
Pharmaceutical Research.2019;36(12)637
[DOI]
13Between pharmaceutical patents and European patients: is a compromise still possible?
Livio Garattini,Anna Padula
Expert Opinion on Therapeutic Patents.2017;27(10)1073
[DOI]
14Large-scale crystallization of acetaminophen trihydrate by a novel stirring technique
Riki Fujimoto,Mihoko Maruyama,Shino Okada,Hiroaki Adachi,Hiroshi Y. Yoshikawa,Kazufumi Takano,Masayuki Imanishi,Katsuo Tsukamoto,Masashi Yoshimura,Yusuke Mori
Applied Physics Express.2019;12(4)045503
[DOI]
15Enantioselectivity of mass spectrometry: Challenges and promises
Hanan Awad,Anas El-Aneed
Mass Spectrometry Reviews.2013;12(4)n/a
[DOI]
16The relationship between medical innovation and health expenditure before and after health reform
Songul Cinaroglu,Onur Baser
Health Policy and Technology.2018;7(4)379
[DOI]
17National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012
Meijia Zhou,Matthew Daubresse,Randall S. Stafford,G. Caleb Alexander,Angelo Scuteri
PLOS ONE.2015;10(3)e0119292
[DOI]
18National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012
Lisa Cosgrove,Akansha Vaswani
PLOS ONE.2019;10(3)71
[DOI]
19National Trends in the Ambulatory Treatment of Hypertension in the United States, 1997-2012
Syed A.A. Rizvi
PLOS ONE.2016;10(3)245
[DOI]
20Necessity of Establishing Chemical Integrity of Polymorphs of Drug Substance Using a Combination of NMR, HPLC, Elemental Analysis, and Solid-State Characterization Techniques: Case Studies
Kamlesh D. Sawant,Tushar A. Naik
Organic Process Research & Development.2013;17(3)519
[DOI]
21Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders
Aleksandra Tarasiuk,Paula Mosinska,Jakub Fichna
Chinese Medicine.2018;13(1)519
[DOI]
22Intellectual property rights derived from academic research and their role in the modern bioeconomy—A guide for scientists
Jan B. Krauss,David Kuttenkeuler
New Biotechnology.2018;40(1)133
[DOI]
  Feedback 
  Subscribe 
  Advertise 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal